|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2005-1-11
|
|
pubmed:abstractText |
To evaluate the efficacy and toxicity of the combination of vinorelbine and interleukin (IL)-2 in patients with metastatic melanoma as second-line chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0735-7907
|
|
pubmed:author |
pubmed-author:AravantinosGG,
pubmed-author:BafaloukosDD,
pubmed-author:BriasoulisEE,
pubmed-author:CastanaOO,
pubmed-author:FountzilasGG,
pubmed-author:FrangiaKK,
pubmed-author:GogasHelenH,
pubmed-author:Hellenic Cooperative Oncology Group,
pubmed-author:IoannovichJJ,
pubmed-author:KalofonosH PHP,
pubmed-author:PanagiotouPP,
pubmed-author:PectasidesDD,
pubmed-author:PolyzosAA,
pubmed-author:TsoutsosDD
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
832-9
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:15641480-Adult,
pubmed-meshheading:15641480-Aged,
pubmed-meshheading:15641480-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15641480-Disease Progression,
pubmed-meshheading:15641480-Drug Resistance, Neoplasm,
pubmed-meshheading:15641480-Female,
pubmed-meshheading:15641480-Humans,
pubmed-meshheading:15641480-Interleukin-2,
pubmed-meshheading:15641480-Male,
pubmed-meshheading:15641480-Melanoma,
pubmed-meshheading:15641480-Middle Aged,
pubmed-meshheading:15641480-Salvage Therapy,
pubmed-meshheading:15641480-Skin Neoplasms,
pubmed-meshheading:15641480-Survival Rate,
pubmed-meshheading:15641480-Time Factors,
pubmed-meshheading:15641480-Vinblastine
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Vinorelbine in combination with interleukin-2 as second-line treatment in patients with metastatic melanoma. A phase II study of the Hellenic Cooperative Oncology Group.
|
|
pubmed:affiliation |
First Department of Medicine, University of Athens, Athens, Greece. hgogas@hol.gr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
